Diabetic retinopathy (DR) is a leading cause of visual impairment ... STDR was defined as the presence of preproliferative DR (R2), proliferative DR (R3) and/or maculopathy (M1). Photographs that were ...
The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...
GlobalData on MSN1d
Regeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
A small percentage have had vision problems, but a direct causal link with the drugs has not been established.
Dec. 12, 2024 — Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback